Actively Recruiting
Risk Factors for Hormonal Therapy Failure in Patients With Endometriosis.
Led by University of Cagliari · Updated on 2024-07-19
247
Participants Needed
1
Research Sites
117 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The primary objective of our study is to determine the percentage of patients with endometriosis who are non-responsive to medical therapy after 12 months and to compare the clinical and ultrasound characteristics of this group of patients (study group) with the clinical and ultrasound characteristics of patients who are responsive to medical therapy (control group). The secondary objective of the study will be to determine the percentage of patients with endometriosis who are non-responsive to medical therapy after 6 months and to compare the clinical and ultrasound characteristics of this group of patients (study group) with the clinical and ultrasound characteristics of patients who are responsive to medical therapy (control group).
CONDITIONS
Official Title
Risk Factors for Hormonal Therapy Failure in Patients With Endometriosis.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 18 and 50 years
- Painful symptoms related to endometriosis such as dyspareunia, dyschezia, dysmenorrhea, chronic pelvic pain, dysuria, or periovulatory pain with at least one symptom scoring above 5 on the Numerical Pain Rating Scale
- Indication for oral hormonal therapy for endometriosis
- Signed informed consent
You will not qualify if you...
- Contraindications to oral hormonal therapy
- Current or past pelvic infections
- History of malignancy or suspicion of malignant gynecological lesions
- Previous pelvic surgery including hysterectomy, salpingectomy, ovarian cyst removal, myomectomy, surgery for endometriosis, or intestinal resections
- History of other causes of chronic pelvic pain
- Postmenopausal status
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Policlinico "Duilio-Casula"
Monserrato, Cagliari, Italy, 09042
Actively Recruiting
Research Team
S
Stefano Angioni, PhD
CONTACT
S
Salvatore Giovanni Vitale, PHD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here